Correlation Between Bank of America and Akari Therapeutics
Can any of the company-specific risk be diversified away by investing in both Bank of America and Akari Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bank of America and Akari Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bank of America and Akari Therapeutics PLC, you can compare the effects of market volatilities on Bank of America and Akari Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bank of America with a short position of Akari Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bank of America and Akari Therapeutics.
Diversification Opportunities for Bank of America and Akari Therapeutics
0.35 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Bank and Akari is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Bank of America and Akari Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akari Therapeutics PLC and Bank of America is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bank of America are associated (or correlated) with Akari Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akari Therapeutics PLC has no effect on the direction of Bank of America i.e., Bank of America and Akari Therapeutics go up and down completely randomly.
Pair Corralation between Bank of America and Akari Therapeutics
Considering the 90-day investment horizon Bank of America is expected to under-perform the Akari Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Bank of America is 4.82 times less risky than Akari Therapeutics. The stock trades about -0.02 of its potential returns per unit of risk. The Akari Therapeutics PLC is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 97.00 in Akari Therapeutics PLC on December 27, 2024 and sell it today you would earn a total of 34.00 from holding Akari Therapeutics PLC or generate 35.05% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Bank of America vs. Akari Therapeutics PLC
Performance |
Timeline |
Bank of America |
Akari Therapeutics PLC |
Bank of America and Akari Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Bank of America and Akari Therapeutics
The main advantage of trading using opposite Bank of America and Akari Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bank of America position performs unexpectedly, Akari Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akari Therapeutics will offset losses from the drop in Akari Therapeutics' long position.Bank of America vs. Citigroup | Bank of America vs. Wells Fargo | Bank of America vs. Toronto Dominion Bank | Bank of America vs. Royal Bank of |
Akari Therapeutics vs. Armata Pharmaceuticals | Akari Therapeutics vs. Anebulo Pharmaceuticals | Akari Therapeutics vs. Processa Pharmaceuticals | Akari Therapeutics vs. Salarius Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |